Mass spectrometric immunoassay for quantitative determination of protein biomarker isoforms.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerEfficient sample preparation in immuno-matrix-assisted laser desorption/ionization mass spectrometry using acoustic trapping.Surface plasmon resonance imaging in arrays coupled with mass spectrometry (SUPRA-MS): proof of concept of on-chip characterization of a potential breast cancer marker in human plasma.Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesDelineation of concentration ranges and longitudinal changes of human plasma protein variants.Mass spectrometry-based protein assays for in vitro diagnostic testing.Immuno-MALDI-MS in human plasma and on-chip biomarker characterizations at the femtomole level.Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1MALDI-target integrated platform for affinity-captured protein digestionParallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoformsMass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.Quantification of protein isoforms in mesenchymal stem cells by reductive dimethylation of lysines in intact proteinsAssuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality IndicatorsRapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumPersonalized Proteomics: The Future of Precision Medicine.Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.Human proteoforms as new targets for clinical mass spectrometry protein tests.Mass spectrometry protein tests: ready for prime time (or not).Development of quantitative mass spectrometric immunoassay for serum amyloid A.Mass Spectrometric Studies of Apolipoprotein Proteoforms and Their Role in Lipid Metabolism and Type 2 Diabetes.Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease.Ultrasensitive electrochemiluminescence immunoassay for tumor marker detection using functionalized Ru-silica@nanoporous gold composite as labels
P2860
Q26738703-2C5A1100-6C64-4F20-92E4-C682F0669FF6Q30441133-CD39879C-8032-4F9B-9AAB-893336A6C641Q31064643-BE570F11-FD02-4B54-9EA1-B243C748B1A3Q33643266-1F2BBBA0-4A6E-486A-B6CE-93585074EBF6Q33793513-7F41AE85-A72E-44D0-81F4-7D41C39F0365Q34216869-92AAABE1-812D-45C3-A1BC-21D3D6FDE38AQ34497653-C1F35A5B-7F7E-4B87-A7FD-B6F1320075B5Q35053898-4FEA7531-A075-431C-BF36-3999E14F4CCDQ35072160-8D34641E-8DED-4AFE-B0E8-111176CD147CQ35130223-86B64B78-CA82-4F89-A3F2-A6D207A6C6D9Q35166976-E2938931-7E50-470A-AFF5-114FB106BD39Q36072219-6BAE1B17-E81E-47FB-A024-FB20409A3936Q36072250-1769C0F0-9A15-4BAF-AD97-5533292A464CQ36230272-FA89891D-CDFE-47A3-97F7-8DE564B8CE0AQ36361741-B7C518F9-1D1C-48D7-A218-8CA42ABE12A2Q37187946-10ED0250-FD72-4CBD-A37D-A6C76E117093Q37426540-E2538DED-ADD6-4654-817F-57D018E267D7Q37566426-B55800DD-1BB6-4F0C-87A3-8803BCC7F6B2Q38649742-3B1F6B7B-4817-45EA-9250-76A644028D77Q38799731-8D8F7276-CA13-4692-B67A-106FFE8CD01AQ46155938-0EBC742A-2E30-448F-95FC-AF8B415E2831Q47163663-ED16FCC8-1DC0-4580-BAC0-2C7D99250657Q53264356-FC6A267A-2002-451D-ADC4-A5F31E5528CEQ57127978-0F17D42D-8BE3-41F8-8CF3-3705B0B61BE7
P2860
Mass spectrometric immunoassay for quantitative determination of protein biomarker isoforms.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@ast
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@en
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@nl
type
label
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@ast
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@en
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@nl
prefLabel
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@ast
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@en
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@nl
P2093
P2860
P356
P1476
Mass spectrometric immunoassay ...... of protein biomarker isoforms.
@en
P2093
Dobrin Nedelkov
Elena Kamcheva
Olgica Trenchevska
P2860
P304
P356
10.1021/PR1007587
P577
2010-09-23T00:00:00Z